PT Bio Farma
- Country
- 🇮🇩Indonesia
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.biofarma.co.id
Clinical Trials
43
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (37 trials with phase data)• Click on a phase to view related trials
Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV
- Conditions
- Antibody Typhoid Vaccine
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- PT Bio Farma
- Target Recruit Count
- 624
- Registration Number
- NCT06921460
- Locations
- 🇮🇩
Department of Child Health Dr. Soetomo Hospital/School of Medicine, Airlangga University, Surabaya, East Java, Jakarta, DKI Jakarta, Indonesia
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
- Conditions
- Vaccine Adverse ReactionVaccine Reaction
- Interventions
- Biological: DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula ABiological: DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula BBiological: Registered DTwP-Hepatitis B-Hib Vaccine and IPV (Sinovac)®
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- PT Bio Farma
- Target Recruit Count
- 465
- Registration Number
- NCT06690515
- Locations
- 🇮🇩
Garuda Primary Health Centre, Bandung, West Java, Indonesia
🇮🇩Ibrahim Adjie Priamry Health Centre, Bandung, West Java, Indonesia
🇮🇩Puter Primary Health Centre, Bandung, West Java, Indonesia
Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination
- Conditions
- COVID-19
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- PT Bio Farma
- Target Recruit Count
- 1208
- Registration Number
- NCT06690502
- Locations
- 🇮🇩
Gambir Public Health Center, Jakarta, Center Jakarta, Indonesia
🇮🇩Kemayoran Public Health Center, Jakarta, Center Jakarta, Indonesia
🇮🇩Menteng Public Health Center, Jakarta, Center Jakarta, Indonesia
Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- PT Bio Farma
- Target Recruit Count
- 220
- Registration Number
- NCT06114641
- Locations
- 🇮🇩
RSUP Dr.Sardjito, Yogyakarta, Yogyakarta, D.I.Yogyakarta, Indonesia
🇮🇩RS Jantung dan Pembuluh Darah Harapan Kita, Jakarta, Jakarta, DKI Jakarta, Indonesia
🇮🇩RSUP Prof. Dr. I.G.N.G Ngoerah, Bali, Bali, Indonesia
Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)
- Conditions
- Human Papilloma Virus Infection
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- PT Bio Farma
- Target Recruit Count
- 900
- Registration Number
- NCT06111911
- Locations
- 🇮🇩
Cipto Mangunkusumo Hospital, Jakarta, DKI Jakarta, Indonesia
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
BioNet and Bio Farma Partner to Accelerate TdaP Vaccine Access Across Southeast Asia
BioNet and PT Bio Farma have signed a strategic MoU to develop and distribute a combined TdaP vaccine targeting tetanus, diphtheria, and acellular recombinant pertussis across ASEAN markets.